YSYazhen Shang

Yazhen Shang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yazhen Shang has a total of 43 co-authors. Here are the top co-authors by number of shared publications:

  • Yan Chen

    Institute of Traditional Chinese Medicine, Chengde Medical University / Hebei Province Key Research Office of Traditional Chinese Medicine Against Dementia / Hebei Province Key Laboratory of Traditional Chinese Medicine Research and Development / Hebei Key Laboratory of Nerve Injury and Repair, Chengde, 067000, China

    3 shared publications
  • Yinhui Yao

    Faculty of Integrated Traditional Chinese and Western Medicine, Hebei University of Chinese Medicine, Shijiazhuang, 050200, China

    3 shared publications
  • Chen Li

    Institute of Traditional Chinese Medicine, Chengde Medical University / Hebei Province Key Research Office of Traditional Chinese Medicine Against Dementia / Hebei Province Key Laboratory of Traditional Chinese Medicine Research and Development / Hebei Key Laboratory of Nerve Injury and Repair, Chengde, 067000, China

    2 shared publications
  • Jianjun Cheng

    Institute of Traditional Chinese Medicine, Chengde Medical College, Chengde, 067000, P.R. China

    2 shared publications
  • Shuai Ma

    Institute of Traditional Chinese Medicine, Chengde Medical College, Chengde, 067000, P.R. China

    2 shared publications
  • Tangtang Song

    Institute of Traditional Chinese Medicine, Chengde Medical University, Chengde, Hebei, 067000, China

    2 shared publications

Latest Publications

  • Exploring the Link Between the Dietary Inflammation Index and Alzheimer’s Disease: Insights from the NHANES Database

    by Shu Tong, Yuxin Zhang, Yan Chen, Yinhui Yao, Chunying Zhao, Yujian Zhai, Yazhen Shang

    Introduction: To explore this potential association, this study analyzed the relationship between the dietary inflammatory index (DII) and the risk of Alzheimer's disease (AD) using data from a national adult cohort in the United States. Methods: The study was a cross-sectional analysis of 116,876 participants from the National Representative Health and Nutrition Survey (NHANES) 1999-2020. To explore the correlation between DII and AD, we used multivariate logistic regression as the primary analysis method and incorporated complex survey weights from the survey to ensure data accuracy. DII from dietary recalls; AD self-reported. Restricted cubic splines (RCS) and Weighted Quantile Sum (WQS) regression were also employed. Sensitivity analyses with IPTW and subgroup evaluations were conducted. Results: Higher DII quartiles were associated with increased AD odds (fully adjusted OR 1.011, 95% CI excluding 1.0). The RCS model confirmed that the link was nonlinear and gradually increasing. A J-shaped relationship was found, with elevated risk at both low and high DII levels. WQS identified 28 dietary components linked to AD, notably protein, alcohol, selenium, and specific fatty acids. Directional consistency was supported across subgroup, sensitivity, and treatment weighting (IPTW) analyses. Discussion: This is the first evidence of a J-shaped DII-AD association in a large U.S. cohort, suggesting that both extreme anti-inflammatory and pro-inflammatory diets may increase AD risk, underscoring the importance of dietary balance. Key drivers include protein, alcohol, selenium, and fatty acids. Causal inference is limited by cross-sectional design. Conclusions: This study found a J-shaped nonlinear relationship between DII scores and AD in a broad U.S. adult sample, with elevated risk at both low and high DII levels.

  • Inhibitory Effects of Flavonoids from the Stems and Leaves of Scutellaria baicalensis Georgi on Oligodendrocyte Pyroptosis Induced by Aβ1-42

    by Tangtang Song, Yazhen Shang

    Introduction: Alzheimer's disease (AD) is characterized not only by gray matter lesions but also by significant white matter damage and oligodendrocyte dysfunction. This study elucidates the pyroptosis-suppressive potential of Scutellaria baicalensis Georgi stem-leaf flavonoids (SSFs) in oligodendroglial lineage cells. Methods: We co-treated rat oligodendrocytes (OLN-93 cell line) with 7.5 μmol/L Aβ₁₋₄₂ to simultaneouslyinduce pyroptosis and SSFs. We observed cell morphology via microscopy, measured cell viability with the MTT assay, and assessed membrane damage using the LDH release assay. We then used qPCR to measure the mRNA levels of myelin-related genes (MBP, MAG, MOG) and pyroptosis-related genes (NLRP3, Caspase-1, GSDMD). We employed Western blotting to quantify the expression of pyroptosis-related proteins.Immunofluorescence was. used to localize myelin proteins whereas pyroptosis indicators and applied PI/Hoechst staining was used to evaluate cell membrane permeability within cells. Results: SSFs at concentrations of 15–60 mg/L significantly improved cell morphology, increased cell survival, reduced LDH release, modulated the expression of relevant genes and proteins, decreased the proportion of cells with impaired membrane integrity, and reduced the fluorescence signal of the pyroptotic execution protein GSDMD. These effects were comparable to those of the commonly used positive control, 60 mg/L Ginkgo biloba extract (GBE). Discussion: This study found that SSFs can alleviate Aβ-induced oligodendrocyte pyroptosis by inhibiting the NLRP3 inflammasome pathway, thereby preserving myelin function. The limitations of this study include the exclusive use of cell line models, the unclear identity of the specific active ingredients in SSFs, and the lack of verification of their blood-brain barrier penetration. Further studies, including in vivo animal experiments, active component isolation, and pharmacokinetic research, are required to evaluate its therapeutic potential for AD fully. Conclusion: SSFs protect oligodendrocytes against Aβ-induced injury by inhibiting the NLRP3 inflammasome pathway.

  • Ginkgo biloba extract safety: Insights from a real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events

    by Yinhui Yao, Jingyi Zhao, Chen Li, Yan Chen, Tianci Zhang, Xianhui Dong, Weijuan Gao, Yazhen Shang


  • Identification of Molecular Correlations of GSDMD with Pyroptosis in Alzheimer's Disease

    by Tangtang Song, Yan Chen, Chen Li, Yinhui Yao, Shuai Ma, Yazhen Shang, Jianjun Cheng

    Aim: An analysis of bioinformatics and cell experiments was performed to verify the relationship between gasdermin D (GSDMD), an executive protein of pyroptosis, and Alzheimer's disease (AD). Methods: The training set GSE33000 was utilized to identify differentially expressed genes (DEGs) in both the AD group and control group, as well as in the GSDMD protein high/low expression group. Subsequently, the weighted gene co-expression network analysis (WGCNA) and the least absolute shrinkage and selection operator (LASSO) regression analysis were conducted, followed by the selection of the key genes for the subsequent Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. The association between GSDMD and AD was assessed and confirmed in the training set GSE33000, as well as in the validation sets GSE5281 and GSE48350. Immunofluorescence (IF) was employed to detect the myelin basic protein (MBP), a distinctive protein found in the rat oligodendrocytes (OLN-93 cells). A range of concentrations (1-15 μmol/L) of β-amyloid 1-42 (Aβ1-42) were exposed to the cells, and the subsequent observations were made regarding cell morphology. Additionally, the assessments were conducted to evaluate the cell viability, the lactate dehydrogenase (LDH) release, the cell membrane permeability, and the GSDMD protein expression. Results: A total of 7,492 DEGs were screened using GSE33000. Subsequently, WGCNA analysis identified 19 genes that exhibited the strongest correlation with clinical traits in AD. Additionally, LASSO regression analysis identified 13 key genes, including GSDMD, AFF1, and ATOH8. Furthermore, the investigation revealed that the key genes were associated with cellular inflammation based on GO and KEGG analyses. Moreover, the area under the curve (AUC) values for the key genes in the training and validation sets were determined to be 0.95 and 0.70, respectively. Significantly, GSDMD demonstrated elevated levels of expression in AD across both datasets. The positivity of MBP expression in cells exceeded 95%. As the concentration of Aβ1-42 action gradually escalated, the detrimental effects on cells progressively intensified, resulting in a gradual decline in cell survival rate, accompanied by an increase in lactate dehydrogenase release, cell membrane permeability, and GSDMD protein expression. Conclusion: The association between GSDMD and AD has been observed, and it has been found that Aβ1-42 can induce a significant upregulation of GSDMD in OLN-93 cells. This suggests that Aβ1-42 has the potential to induce cellular pyroptosis and can serve as a valuable cellular pyroptosis model for the study of AD.


  • Open Access

    The Molecular Mechanism of Scutellaria Barbata Flavonoids in Promoting Neurogenesis and Improving Memory Impairment Mediated by CREB Phosphorylation in Rats

    by Xinyang Liu, Yuling Liu, Jianjun Cheng, Yang Gao, Chunying Zhao, Shuai Ma, Caixia Li, Yazhen Shang

    Background The present study was aimed to investigate the effect and molecular mechanism of Scutellaria barbata flavonoids (SBFs) in promoting neurogenesis and improving memory impairment mediated by CREB phosphorylation in rats. Methods Alzheimer’s disease (AD) model was established by intracerebroventricular injection of amyloid beta-peptide 25–35 (Aβ25−35) in combination with aluminum trichloride (AlCl3) and recombinant human transforming growth factor-β1 (RHTGF-β1) (composited Aβ) in rats. The Morris water maze was used to screen the successful AD model of rats. The screened successful AD model rats were randomly divided into three groups including a model group and two drug groups of 140 mg/kg SBFs and 0.5 mg/kg Rolipram (Positive control drug). After administration for 38 days, the Morris water maze test was used to measure the learning and memory ability of the rats. HE staining was used to observe the morphology of neurons in the hippocampus and cerebral cortex regionsof the rats' brains. Immunohistochemistry was used to detect the expression of NeuN in the hippocampal gyrus of rats. The mRNA expression of TrkB, RSK,CREB, and BDNF and the protein expression of NeuN, TrkB, RSK, P-CREB-Ser133, and BDNF in the hippocampus and cerebral cortex of the rats were assayed by quantitative real-time PCR (qPCR) and Western blotting methods. Results Intracerebroventricular injection of composited Aβ induced memory impairment, impaired neurons, decreased the protein expression of NeuN in the hippocampal gyrus, increased the mRNA expression levels of TrkB, RSK and BDNF, decreased the mRNA expression level of CREB and the protein expression levels of NeuN, TrkB, RSK, P-CREB-Ser133 and BDNF in the hippocampus and cerebral cortex of rats. However, SBFs attenuated memory impairment which was induced by composited Aβ in rats and ameliorated neuropathological changes in the brain, increased the expression of NeuN protein in the hippocampal gyrus, and regulated mRNA and protein expressions in composited Aβ treated rats. Rolipram ameliorated learning and memory disorder induced by composited Aβ, increased the protein expression of P-CREB-Ser133, increased the expression of NeuN protein in the hippocampal gyrus, promoted neurogenesis, and improved the neuropathological changes in the brain. The effect of SBFs was also similar to Rolipram. Conclusion The effect of SBFs was consistent with the positive control drug Rolipram. SBFs could promote neurogenesis and improve learning and memory impairment in AD rats, and its mechanism was mediated by CREB phosphorylation.

  • Open Access

    The improvement and mechanism of Scutellaria baicalensis Georgi stems and leaves flavonoids on okadaic acid-induced learning and memory impairment in rats

    by Ma Shuai, Xu Congcong, Dong Yongcai, Li Caixia, Yazhen Shang

    Background AD is a progressive neurodegenerative disease that seriously threatens the physical and mental health for the elderly. The disease is pathologically associated with Aβ plaque deposition, tau hyperphosphorylation, cholinergic damage, oxidative stress and neuroinflammation. okadaic acid (OA), an inhibitor of protein phosphatases PP1 and PP2A, can reduce the dephosphorylation of phosphorylated tau protein and result in the hyperphosphorylation of tau protein, which in turn leads to NFT deposition and indirectly induces AD. Therefore, the brain injury in mimic AD model established by intracerebroventricular injection of OA conforms to the pathogenesis of AD in rats. Objective To investigate the effect and mechanism of Scutellaria baicalensis Georgi stems and leaves flavonoids (SSFs) on learning and memory impairment induced by intracerebroventricular injection of OA in rats. Methods The mimic AD model of memory impairment of rats was established by intracerebroventricular injection of OA. Morris water maze was to screen the successful model of memory impairment. The successful model rats were randomly divided into model group, three doses of groups for SSFs 25, 50, and 100 mg/kg, and positive drug Ginkgo biloba tablet (GLT) 200 mg/kg group. The rats’ learning and memory abilities were detected with the Morris water maze. The morphological changes of nerve cells were observed by hematoxylin-eosin (HE) staining. The Choline acetyltransferase (ChAT) protein expressions were detected with immunohistochemistry (IHC). The phosphorylation level of tau protein at Ser262 and Ser396 sites was assayed with Western blotting (WB). The activities of inducible nitric oxide synthase (iNOS) and constitutive nitric oxide synthase (cNOS) were measured with ultraviolet spectrophotometry. Enzyme-linked immunosorbent assay (ELISA) was used to detect the level of inflammatory factors interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6). Results The intracerebroventricular injection of OA caused the rats’ learning and memory impairment and neuropathological changes. The protein expression of ChAT was reduced (P < 0.01) and the phosphorylation levels of tau protein at Ser262 and Ser396 were significantly increased (P < 0.01), the activity of iNOS increased (P < 0.01) and cNOS decreased (P < 0.05) in the hippocampus and cerebral cortex. The levels of IL-1β and TNF-α in the cerebral cortex were increased (P < 0.01), and the level of IL-6 was decreased (P < 0.05). The three doses of SSFs and GLT treatment to rats can differently ameliorate the above abnormal changes caused by OA. Conclusion SSFs can improve the rats’ learning and memory impairment caused by intracerebroventricular injection of OA and the effective mechanism may be related to the positive regulation in ChAT protein expression, tau hyperphosphorylation, NOS activity, and inflammatory cytokine levels.

  • Flavonoids from Stem and Leaf of Scutellaria Baicalensis Georgi Inhibit the Phosphorylation on Multi-sites of Tau Protein Induced by Okadaic Acid and the Regulative Mechanism of Protein Kinases in Rats

    by Yang Gao, Xiao-Qing Wang, Shuai Ma, Yong-Cai Dong, Ya-Zhen Shang

    Aim: The present study aims to investigate the effect of flavonoids from stem and leaf of Scutellaria Baicalensis Georgi (SSF) on multi-sites phosphorylation of tau protein in the cerebral cortex and hippocampus of rats induced by okadaic acid (OA) and the regulative mechanism of the protein kinases. Methods: The model of AD-like memory impairment and neuronal injuries was established in male SD rats who were microinjected with OA (200 ng/kg) to establish a memory impairment model and screened for successful model rats by Morris water maze on day 21 after surgery. The successful model rats were continuously administered with intragastric infusion (ig) SSF 25, 50 and 100 mg/kg or Ginkgo biloba leaves flavonoids (GLF) 200 mg/kg for 36 d. The relative protein expressed levels of phosphorylated tau protein at sites of Ser199, Ser202, Ser214, Ser404 and Thr231, protein kinases (CDK5, PKA, pTyr216-GSK3β and pSer9-GSK3β) were detected by Western blotting. Results: The relative protein expressed levels of p-tau(Ser199), p-tau(Ser202), p-tau(Ser214), p-- tau(Ser404), p-tau(Thr231) and pTyr216-GSK3β were significantly increased in both cerebral cortex and hippocampus regions of the model rats subjected to intracerebroventricular injection of OA (P<0.01), while the protein expressed levels of CDK5, PKA and pSer9-GSK3β (P<0.01) were reduced. SSF can dramatically reverse these increments in phosphorylated tau protein levels (P<0.01) and differently regulate the protein expressed levels of CDK5, PKA and GSK3β (P<0.01) in rats’ cerebral cortex and hippocampus induced by OA. GLF also exhibit a similar effect to SSF. Conclusion: The results demonstrated that SSF could inhibit the hyperphosphorylation of tau in rats’ cerebral cortex and hippocampus induced by microinjection of OA, which may be related to the activities of protein kinase CDK5, PKA and GSK3β.


  • Open Access

    Anthocyanins: Novel Antioxidants in Diseases Prevention and Human Health

    by Shang Yazhen, Wang Wenju, Zhu Panpan, Ye Yuanyuan, Dai Panpan, Zhao Wusen, Wang Yanling

    Anthocyanins are a category of water-soluble natural pigments that exist widely in all kinds of vegetables, fruits, and seeds. In fact, the chemical nature of anthocyanins is a group of compounds, and possesses antioxidant capacity like flavonoids. Anthocyanins show antioxidant activity by scavenging free radicals, activating antioxidant enzyme, and chelating metal ions. Anthocyanins, therefore, are recognized as one of the most effective natural antioxidant in the human body. Anthocyanins for a variety of disease prevention and health care are closely related to their strong antioxidant activity and scavenging free radical ability. The present chapter reviewed anthocyanins eliminating free radicals for preventing neoplasm, modulating antioxidant enzyme for preventing Alzheimer’s disease, losing weight for preventing diabetes, regulating lipid metabolism for preventing cardiovascular disease, and inhibiting photoreceptor apoptosis for treating xerophthalmia and for other diseases treated. In addition, some healthy food added of anthocyanins was used as precaution for some diseases, else, there are some cosmetics added with anthocyanins, including sunscreen, creams, mouthwash, and shampoo. Specific creams for characteristics of Chinese old people skin in Chinese Company were developed and achieved anti-wrinkle and moisturizing efficacy. Simultaneously, anthocyanins can also be as a food additive to lactic acid milk, cakes, and other food.


  • Open Access

    Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein

    by Wu Xiaoguang, Cheng Jianjun, Cao Qinying, Zhang Hui, Yang Lukun, Shang Yazhen

    Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and is accompanied by neuron loss and structure change. With the increase of AD patients worldwide, the pathology and treatment of the disease has become a focus in the International Pharmaceutical Industry. Thus, the establishment of the animal model to mimic AD in the laboratory is of great importance. Here, we describe a detailed protocol for establishing a mimic of AD in a rat animal model though intracerebroventricular injection of amyloid beta protein 25-35 (Aβ25-35) combined with aluminum trichloride (AlCl3) and anterodorsal thalamic nucleus injection of recombinant human transforming growth factor-β1 (RHTGF-β1) to rats. The related markers of AD were measured, including: spatial memory, neuronal structure and substructure, neuronal Aβ, and neurofibrillary tangles (NFT) production. This rat model demonstrates spatial memory impairment, neuronal structure and substructure pathological changes, neuron intracellular Aβ burden, and NFT aggregation, and provides a close mimic of the neuronal structure and function disorder to that of clinical AD patients. Thus, the presented AD rat modelprovides a valuable in vivo tool for exploring neuronal function, neuronal pathology, and drug screening of AD.